For the year ending 2025-12-31, XBIO made $2,976,411 in revenue. -$2,680,860 in net income. Net profit margin of -90.07%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Total revenue | 2,976,411 | |||
| Research and development | 3,065,484 | |||
| General and administrative | 2,745,509 | |||
| Total operating costs and expenses | 5,810,993 | |||
| Loss from operations | -2,834,582 | |||
| Other income (expense) | 5,725 | |||
| Interest income, net | 147,997 | |||
| Total other income, net | 153,722 | |||
| Net loss | -2,680,860 | |||
| Basic EPS | -1.58 | |||
| Diluted EPS | -1.58 | |||
| Basic Average Shares | 1,701,571 | |||
| Diluted Average Shares | 1,701,571 | |||
Xenetic Biosciences, Inc. (XBIO)
Xenetic Biosciences, Inc. (XBIO)